Expression of the genes dualoxidase2, lipocalin 2 and regenerating islet-derived 1 alpha in Crohn's disease

References

• Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53: 685–93
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44–54
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412–21
   PubMed Web of Science ®Google Scholar
• Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003; 52: 237–42
   PubMed Web of Science ®Google Scholar
• Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 106–11
   PubMed Web of Science ®Google Scholar
• Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881–4
   PubMed Web of Science ®Google Scholar
• Nielsen SE, Nielsen OH, Vainer B, Claesson MH. Inflammatory bowel disease: do microorganisms play a role?. Ugeskr Laeger 2002; 164: 5947–50
   PubMedGoogle Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
   PubMed Web of Science ®Google Scholar
• Mathew CG, Lewis CM. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 2004; 13 Spec No 1: R161–8
   PubMed Web of Science ®Google Scholar
• Barcelo-Batllori S, Andre M, Servis C, Levy N, Takikawa O, Michetti P, et al. Proteomic analysis of cytokine-induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics 2002; 2: 551–60
   PubMed Web of Science ®Google Scholar
• Langmann T, Moehle C, Mauerer R, Scharl M, Liebisch G, Zahn A, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004; 127: 26–40
   PubMed Web of Science ®Google Scholar
• Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK, et al. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 2004; 13: 1715–25
   PubMed Web of Science ®Google Scholar
• Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, et al. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis 2004; 10: 1–14
   PubMed Web of Science ®Google Scholar
• Uthoff SM, Eichenberger MR, Lewis RK, Fox MP, Hamilton CJ, McAuliffe TL, et al. Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. Int J Oncol 2001; 19: 803–10
   PubMed Web of Science ®Google Scholar
• Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10: 445–56
   PubMed Web of Science ®Google Scholar
• Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 2000; 4: 1–11
   PubMed Web of Science ®Google Scholar
• Zeng H, Carlson AQ, Guo Y, Yu Y, Collier-Hyams LS, Madara JL, et al. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J Immunol 2003; 171: 3668–74
   PubMed Web of Science ®Google Scholar
• Fukushima K, Ogawa H, Takahashi K, Naito H, Funayama Y, Kitayama T, et al. Non-pathogenic bacteria modulate colonic epithelial gene expression in germ-free mice. Scand J Gastroenterol 2003; 38: 626–34
   PubMed Web of Science ®Google Scholar
• Ogawa H, Fukushima K, Naito H, Funayama Y, Unno M, Takahashi K, et al. Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm Bowel Dis 2003; 9: 162–70
   PubMed Web of Science ®Google Scholar
• Csillag C, Nielsen OH, Borup R, Nielsen FC. Microarrays and Crohn's disease: collecting reliable information. Scand J Gastroenterol 2005; 40: 369–77
   PubMed Web of Science ®Google Scholar
• Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003; 12: 755–62
   PubMed Web of Science ®Google Scholar
• Distler P, Holt PR. Are right- and left-sided colon neoplasms distinct tumors?. Dig Dis 1997; 15: 302–11
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962–87: a six-fold increase in incidence. Scand J Gastroenterol 1992; 27: 609–14
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417–29
   PubMed Web of Science ®Google Scholar
• Thompson WG. Irritable bowel syndrome: pathogenesis and management. Lancet 1993; 341: 1569–72
   PubMed Web of Science ®Google Scholar
• Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Crohn's disease: monitoring disease activity [review]. Aliment Pharmacol Ther 2003; 17 Suppl 2: 11–7
   PubMed Web of Science ®Google Scholar
• Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8–15
   PubMed Web of Science ®Google Scholar
• Day D, Jass J, Price A, Shepherd N, Sloan J, Talbot I, et al. Morson and Dawson's gastrointestinal pathology4th ed. Blackwell Science, OxfordUK 2003; 505–7
   Google Scholar
• Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15: 532–7
   PubMed Web of Science ®Google Scholar
• Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98: 31–6
   PubMed Web of Science ®Google Scholar
• El Hassani RA, Benfares N, Caillou B, Talbot M, Sabourin JC, Belotte V, et al. Dual oxidase2 is expressed all along the digestive tract. Am J Physiol Gastrointest Liver Physiol 2005; 288: 933–42
   Web of Science ®Google Scholar
• Dieckgraefe BK, Crimmins DL, Landt V, Houchen C, Anant S, Porche-Sorbet R, et al. Expression of the regenerating gene family in inflammatory bowel disease mucosa: Reg Ialpha up-regulation, processing, and antiapoptotic activity. J Invest Med 2002; 50: 421–34
   PubMed Web of Science ®Google Scholar
• DUOX2. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=606759.
   Google Scholar
• Geiszt M, Witta J, Baffi J, Lekstrom K, Leto TL. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. Faseb J 2003; 17: 1502–4
   PubMed Web of Science ®Google Scholar
• Harper RW, Xu C, Eiserich JP, Chen Y, Kao C-Y, Thai P, et al. Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 2005; 579: 4911–7
   PubMed Web of Science ®Google Scholar
• Schwarzer C, Machen TE, Illek B, Fischer H. NADPH oxidase-dependent acid production in airway epithelial cells. J Biol Chem 2004; 279: 36454–61
   PubMed Web of Science ®Google Scholar
• Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Deme D, Virion A. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas. J Biol Chem 1999; 274: 37265–9
   PubMed Web of Science ®Google Scholar
• De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, et al. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 2000; 275: 23227–33
   PubMed Web of Science ®Google Scholar
• Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, de Vijlder JJ, et al. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002; 347: 95–102
   PubMed Web of Science ®Google Scholar
• Caillou B, Dupuy C, Lacroix L, Nocera M, Talbot M, Ohayon R, et al. Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. J Clin Endocrinol Metab 2001; 86: 3351–8
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Ahnfelt-Ronne I. Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin Wochenschr 1991; 69: 995–1000
   PubMedGoogle Scholar
• Ha EM, Oh CT, Bae YS, Lee WJ. A direct role for dual oxidase in Drosophila gut immunity. Science 2005; 310: 847–50
   PubMed Web of Science ®Google Scholar
• LCN2. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600181.
   Google Scholar
• Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000; 1482: 272–83
   PubMed Web of Science ®Google Scholar
• Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002; 10: 1045–56
   PubMed Web of Science ®Google Scholar
• Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002; 10: 1033–43
   PubMed Web of Science ®Google Scholar
• Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion. Faseb J 2005; 19: 1881–3
   PubMed Web of Science ®Google Scholar
• Nelson AL, Barasch JM, Bunte RM, Weiser JN. Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol 2005; 7: 1404–17
   PubMed Web of Science ®Google Scholar
• Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 2005; 13: 29–41
   PubMed Web of Science ®Google Scholar
• Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432: 917–21
   PubMed Web of Science ®Google Scholar
• Andrews NC. Iron homeostasis: insights from genetics and animal models. Nat Rev Genet 2000; 1: 208–17
   PubMed Web of Science ®Google Scholar
• Ratledge C, Dover LG. Iron metabolism in pathogenic bacteria. Annu Rev Microbiol 2000; 54: 881–941
   PubMed Web of Science ®Google Scholar
• Winkelmann G. Microbial siderophore-mediated transport. Biochem Soc Trans 2002; 30: 691–6
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085–8
   PubMed Web of Science ®Google Scholar
• Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274: 33419–25
   PubMed Web of Science ®Google Scholar
• Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099–103
   PubMed Web of Science ®Google Scholar
• Burczynski ME, Peterson RL, Twine NC, Zuberek KA, Brodeur BJ, Casciotti L, et al. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diagn 2006; 8: 51–61
   PubMed Web of Science ®Google Scholar
• REG1A. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=167770.
   Google Scholar
• Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H. Complete nucleotide sequence of human REG gene and its expression in normal and tumoral tissues. The REG protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 1990; 265: 7432–9
   PubMed Web of Science ®Google Scholar
• Kimura N, Yonekura H, Okamoto H, Nagura H. Expression of human regenerating gene mRNA and its product in normal and neoplastic human pancreas. Cancer 1992; 70: 1857–63
   PubMed Web of Science ®Google Scholar
• Sekikawa A, Fukui H, Fujii S, Nanakin A, Kanda N, Uenoyama Y, et al. Possible role of REG I[alpha] protein in ulcerative colitis and colitic cancer. Gut 2005; 54: 1437–44
   PubMed Web of Science ®Google Scholar
• Fukui H, Fujii S, Takeda J, Kayahara T, Sekikawa A, Nanakin A, et al. Expression of REG I alpha protein in human gastric cancers. Digestion 2004; 69: 177–84
   PubMed Web of Science ®Google Scholar
• Higham AD, Bishop LA, Dimaline R, Blackmore CG, Dobbins AC, Varro A, et al. Mutations of REGI alpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia. Gastroenterology 1999; 116: 1310–8
   PubMed Web of Science ®Google Scholar
• Iovanna J, Frigerio JM, Dusetti N, Ramare F, Raibaud P, Dagorn JC. Lithostathine, an inhibitor of CaCO3 crystal growth in pancreatic juice, induces bacterial aggregation. Pancreas 1993; 8: 597–601
   PubMed Web of Science ®Google Scholar
• Cliffe LJ, Humphreys NE, Lane TE, Potten CS, Booth C, Grencis RK. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 2005; 308: 1463–5
   PubMed Web of Science ®Google Scholar
• Paavola-Sakki P, Ollikainen V, Helio T, Halme L, Turunen U, Lahermo P, et al. Genome-wide search in Finnish families with inflammatory bowel disease provides evidence for novel susceptibility loci. Eur J Hum Genet 2003; 11: 112–20
   PubMed Web of Science ®Google Scholar
• Grasberger H, Refetoff S. Identification of the maturation factor for dual oxidase: evolution Of a eukaryotic operon equivalent. J Biol Chem 2006; 281: 18269–72
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004; 53: 1658–64
   PubMed Web of Science ®Google Scholar